Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.
GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.
GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with Pharmacia.
Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.
Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.
AstraZeneca faces a major anti-competition investigation after the European Commission accused the company of obstructing competition to its...
The battle to buy Oxford GlycoSciences has intensified following the acquisition of a 10% stake in the company by Celltech.
Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.
Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical development.
The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance for their merger.
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches